ArticleLung2016
Hazard Ratio of Smoking on Lung Cancer in Korea According to Histological Type and Gender.
Article in Lung, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.
- Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis.BMJ open · 2018Pooled it
- Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.BMC health services research · 2017Pooled it
- Clinical significance of miR-9-5p in NSCLC and its relationship with smoking.Frontiers in oncology · 2024Article
- Dose-response risks of all-cause, cancer, and cardiovascular disease mortality according to sex-specific cigarette smoking pack-year quantiles.Tobacco induced diseases · 2024Article
- Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study.Journal of epidemiology · 2023Article
- Lung cancer risk and exposure to air pollution: a multicenter North China case-control study involving 14604 subjects.BMC pulmonary medicine · 2023Article
- Health effects associated with smoking: a Burden of Proof study.Nature medicine · 2022Article
- Analysis of Histopathological Findings of Lung Carcinoma in Czech Black Coal Miners in Association with Coal Workers' Pneumoconiosis.International journal of environmental research and public health · 2022Article
- Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China.Frontiers in oncology · 2022Article
- Ambient Cumulative PM2.5 Exposure and the Risk of Lung Cancer Incidence and Mortality: A Retrospective Cohort Study.International journal of environmental research and public health · 2021Article
- Article
- Catalog of Lung Cancer Gene Mutations Among Chinese Patients.Frontiers in oncology · 2020Article
- Diagnostic, progressive and prognostic performance of mInternational journal of biological sciences · 2020Article
- Risk factors for nicotine dependence in Chinese patients with lung cancer.The Journal of international medical research · 2019Article
- Indoor Radon and Lung Cancer: Estimation of Attributable Risk, Disease Burden, and Effects of Mitigation.Yonsei medical journal · 2018Article
- Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor.Scientific reports · 2018Article
- Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea.BMJ open · 2017Article
- [Effect of Smoking on Lung Cancer Histology and Its Epidemiology in Chinese Male].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2017Article
- Assessing Health Impacts of Pictorial Health Warning Labels on Cigarette Packs in Korea Using DYNAMO-HIA.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUsing nationwide cancer incidence data, we examined whether the strength of the association of cigarette smoking with lung cancer risk differs according to major histological type and gender, taking account of other risk factors in the Korean population.
methodsThe study population derived from government employees and teachers aged 20 years and over who participated in a national health examination program in 1998 or 1999. Total study subjects were 1,357,447. After excluding 1556 subjects who were treated with lung cancer during 1998-2000, we restricted our analysis to 1,355,891 cases. We followed up those 1,355,891 subjects who were cancer-free at baseline until December 31, 2010. The incident cancer cases were identified from the Korea Central Cancer Registry, which is a nationwide hospital-based cancer registry system that includes 94 % of the university hospitals and 96 % of the resident training hospitals of the country.
resultsA higher risk for having ever smoked was observed for squamous-cell and small-cell carcinoma in both men and women. Heavy and long-term smokers were at higher risk for these carcinomas. Significant associations with quantity and duration-related factors were observed mainly among men. These findings indicate that smoking is closely related to the risk of squamous-cell and small-cell carcinoma among women as well as men. However, the magnitude of smoking-related lung cancer risk is likely to differ between men and women.
conclusionThe hazard ratios for all types of lung cancer were significantly higher in male current smokers than in male never smokers. In case of women, the hazard ratios for adenocarcinoma were not different between current smokers and never smokers. The hazard ratios we found, however, were lower than those reported in Western countries and in Korea, but consistent with those reported in North-eastern Asian countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.